Are you interested in optimizing your treatment?
This world-renown GIST expert from Europe will share his wealth of experience and insight about how he has helped patients live longer, and how he consults with fellow physicians on the best treatment plan for their patients.
Dr. Peter Reichardt is Assistant Professor and Head of the Department of Oncology and Palliative Care at the Helios Klinikum Berlin-Buch in Berlin, Germany, and is Director of the Cancer Center Berlin-Buch and the Sarcoma Center Berlin-Brandenburg.
In this webcast Dr. Reichardt will discuss surgery for metastatic disease, imatinib plasma level testing, and the management of side effects.
He will also cover dosing, dose escalation and dose schedules, and will explain mutations and the importance of mutational testing.
About the Presenter:
Dr. Peter Reichardt trained in internal medicine and haematology/oncology at the University of Heidelberg and at the MD Anderson Cancer Center, Houston, TX, USA. From 1992 to 2007, he was a consultant at the Charité University Hospital in Berlin. Dr. Reichardt has led and conducted multiple clinical trials in bone sarcomas, soft tissue sarcomas, and gastrointestinal stromal tumours in the adjuvant, advanced, and refractory settings.Technical Tips to Join Meeting:
- This is a web only meeting, accessed only by your internet connection. Participants are encouraged to use the web link automatically provided after registration and to use computer speakers (and/or headsets if available) to hear the audio portion of the meeting. Please log in at least ten minutes prior to the start of the webinar.
- Please ensure you have an updated version of Adobe Flash Player (Google Chrome has Flash built in).
- If you are using a mobile device or tablet, in order to view and hear the conference, download the ReadyTalk App from your App store.
Disclaimer:
We cannot provide individual medical advice during this webcast. Information provided in this webcast is not intended as a substitute for your physician’s guidance and care.
